NCT06538038 2026-03-16
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
PrECOG, LLC.
Qianfoshan Hospital
Aetion, Inc.
Aetion, Inc.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Xiangya Hospital of Central South University
Tianjin Medical University Cancer Institute and Hospital
European Lung Cancer Working Party
Sungkyunkwan University